BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun H, Sun Y. Lidocaine inhibits proliferation and metastasis of lung cancer cell via regulation of miR-539/EGFR axis. Artif Cells Nanomed Biotechnol 2019;47:2866-74. [PMID: 31299862 DOI: 10.1080/21691401.2019.1636807] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Song Z, Tan J. Effects of Anesthesia and Anesthetic Techniques on Metastasis of Lung Cancers: A Narrative Review. CMAR 2022;Volume 14:189-204. [DOI: 10.2147/cmar.s343772] [Reference Citation Analysis]
2 Wen J, Li X, Ding Y, Zheng S, Xiao Y. Lidocaine inhibits glioma cell proliferation, migration and invasion by modulating the circEZH2/miR-181b-5p pathway. Neuroreport 2021;32:52-60. [PMID: 33252475 DOI: 10.1097/WNR.0000000000001560] [Reference Citation Analysis]
3 Cata JP, Guerra C, Soto G, Ramirez MF. Anesthesia Options and the Recurrence of Cancer: What We Know so Far? Local Reg Anesth 2020;13:57-72. [PMID: 32765061 DOI: 10.2147/LRA.S240567] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
4 Hao J, Zhang W, Huang Z. Bupivacaine modulates the apoptosis and ferroptosis in bladder cancer via phosphatidylinositol 3-kinase (PI3K)/AKT pathway. Bioengineered 2022;13:6794-806. [PMID: 35246010 DOI: 10.1080/21655979.2022.2036909] [Reference Citation Analysis]
5 Guo L, Li H, Li W, Tang J. Construction and investigation of a combined hypoxia and stemness index lncRNA-associated ceRNA regulatory network in lung adenocarcinoma. BMC Med Genomics 2020;13:166. [PMID: 33148251 DOI: 10.1186/s12920-020-00816-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Li D, Yang X, Li B, Yang C, Sun J, Yu M, Wang H, Lu Y. Lidocaine liposome modified with folic acid suppresses the proliferation and motility of glioma cells via targeting the PI3K/AKT pathway. Exp Ther Med 2021;22:1025. [PMID: 34373711 DOI: 10.3892/etm.2021.10457] [Reference Citation Analysis]
7 Xue H, Liu J, Shi L, Yang H. Overexpressed microRNA-539-5p inhibits inflammatory response of neurons to impede the progression of cerebral ischemic injury by histone deacetylase 1. Am J Physiol Cell Physiol 2020;319:C381-91. [PMID: 32491927 DOI: 10.1152/ajpcell.00576.2019] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Du J, Zhang L, Ma H, Wang Y, Wang P. Lidocaine Suppresses Cell Proliferation and Aerobic Glycolysis by Regulating circHOMER1/miR-138-5p/HEY1 Axis in Colorectal Cancer. Cancer Manag Res 2020;12:5009-22. [PMID: 32612388 DOI: 10.2147/CMAR.S244973] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
9 Tabnak P, Masrouri S, Geraylow KR, Zarei M, Esmailpoor ZH. Targeting miRNAs with anesthetics in cancer: Current understanding and future perspectives. Biomed Pharmacother 2021;144:112309. [PMID: 34653761 DOI: 10.1016/j.biopha.2021.112309] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Cappiello F, Ranieri D, Carnicelli V, Casciaro B, Chen HT, Ferrera L, Di YP, Mangoni ML. Bronchial epithelium repair by Esculentin-1a-derived antimicrobial peptides: involvement of metalloproteinase-9 and interleukin-8, and evaluation of peptides' immunogenicity. Sci Rep 2019;9:18988. [PMID: 31831857 DOI: 10.1038/s41598-019-55426-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
11 Li M, Jiang H, Gu K, Sun X, Gu J, Li C, Wang G. Lidocaine Alleviates Neuropathic Pain and Neuroinflammation by Inhibiting HMGB1 Expression to Mediate MIP-1α/CCR1 Pathway. J Neuroimmune Pharmacol 2021;16:318-33. [DOI: 10.1007/s11481-020-09913-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Li Y, Yi L, Li X, Li Y. Benzodiazepines safeguards nerve cells from the toxicity of lidocaine via miR-133a-3p/EGFR pathway. Transpl Immunol 2021;:101510. [PMID: 34856331 DOI: 10.1016/j.trim.2021.101510] [Reference Citation Analysis]
13 Zhao L, Ma N, Liu G, Mao N, Chen F, Li J. Lidocaine Inhibits Hepatocellular Carcinoma Development by Modulating circ_ITCH/miR-421/CPEB3 Axis. Dig Dis Sci 2021. [PMID: 33433806 DOI: 10.1007/s10620-020-06787-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zhang X, Gu G, Li X, Zhang C. Lidocaine alleviates cisplatin resistance and inhibits migration of MGC-803/DDP cells through decreasing miR-10b. Cell Cycle 2020;19:2530-7. [PMID: 32892697 DOI: 10.1080/15384101.2020.1809914] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
15 Zhang C, Xie C, Lu Y. Local Anesthetic Lidocaine and Cancer: Insight Into Tumor Progression and Recurrence. Front Oncol 2021;11:669746. [PMID: 34249706 DOI: 10.3389/fonc.2021.669746] [Reference Citation Analysis]
16 Zhou D, Wang L, Cui Q, Iftikhar R, Xia Y, Xu P. Repositioning Lidocaine as an Anticancer Drug: The Role Beyond Anesthesia. Front Cell Dev Biol 2020;8:565. [PMID: 32766241 DOI: 10.3389/fcell.2020.00565] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
17 Sun D, Li YC, Zhang XY. Lidocaine Promoted Ferroptosis by Targeting miR-382-5p /SLC7A11 Axis in Ovarian and Breast Cancer. Front Pharmacol 2021;12:681223. [PMID: 34122108 DOI: 10.3389/fphar.2021.681223] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
18 Gong W, Martin TA, Sanders AJ, Hargest R, Jiang A, Sun P, Jiang WG. Influence of anaesthetics on the production of cancer cell motogens, stromal cell-derived factor-1 and hepatocyte growth factor by fibroblasts. Oncol Lett 2021;21:140. [PMID: 33552259 DOI: 10.3892/ol.2020.12401] [Reference Citation Analysis]
19 Müller SD, Ziegler JSH, Piegeler T. Local Anesthetics and Recurrence after Cancer Surgery-What's New? A Narrative Review. J Clin Med 2021;10:719. [PMID: 33670434 DOI: 10.3390/jcm10040719] [Reference Citation Analysis]
20 Wall TP, Buggy DJ. Perioperative Intravenous Lidocaine and Metastatic Cancer Recurrence - A Narrative Review. Front Oncol 2021;11:688896. [PMID: 34408981 DOI: 10.3389/fonc.2021.688896] [Reference Citation Analysis]
21 Ji W, Zhang X, Sun G, Wang X, Liu J, Bian J, Bo L. Effect of perioperative intravenous lidocaine on postoperative outcomes in patients undergoing resection of colorectal cancer: a protocol for systematic review and meta-analysis. BMJ Open 2021;11:e048803. [PMID: 34426465 DOI: 10.1136/bmjopen-2021-048803] [Reference Citation Analysis]
22 Xu P, Zhang S, Tan L, Wang L, Yang Z, Li J. Local Anesthetic Ropivacaine Exhibits Therapeutic Effects in Cancers. Front Oncol 2022;12:836882. [PMID: 35186766 DOI: 10.3389/fonc.2022.836882] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Ju C, Zhou J, Miao H, Chen X, Zhang Q. Bupivacaine suppresses the progression of gastric cancer through regulating circ_0000376/miR-145-5p axis. BMC Anesthesiol 2020;20:275. [PMID: 33126850 DOI: 10.1186/s12871-020-01179-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
24 Liu H, Cheng J, Xu H, Wan Z. Lidocaine has antitumor effect on hepatocellular carcinoma via the circ_DYNC1H1/miR-520a-3p/USP14 axis. Open Life Sci 2021;16:766-80. [PMID: 34435133 DOI: 10.1515/biol-2021-0072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Liu H, Dilger JP, Lin J. Effects of local anesthetics on cancer cells. Pharmacol Ther 2020;212:107558. [PMID: 32343985 DOI: 10.1016/j.pharmthera.2020.107558] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
26 Ramirez MF, Cata JP. Anesthesia Techniques and Long-Term Oncological Outcomes. Front Oncol 2021;11:788918. [PMID: 34956903 DOI: 10.3389/fonc.2021.788918] [Reference Citation Analysis]
27 Fan X, Wang D, Chen X, Wang R. Effects of Anesthesia on Postoperative Recurrence and Metastasis of Malignant Tumors. Cancer Manag Res 2020;12:7619-33. [PMID: 32922072 DOI: 10.2147/CMAR.S265529] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
28 Abadi AJ, Zarrabi A, Gholami MH, Mirzaei S, Hashemi F, Zabolian A, Entezari M, Hushmandi K, Ashrafizadeh M, Khan H, Kumar AP. Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers. Biomolecules 2021;11:304. [PMID: 33670518 DOI: 10.3390/biom11020304] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
29 Xing B, Yang L, Cui Y. Lidocaine inhibited migration of NSCLCA549 cells via the CXCR4 regulation. Cancer Biomark 2021. [PMID: 34334384 DOI: 10.3233/CBM-210249] [Reference Citation Analysis]
30 Xue L, Shen Y, Zhai Z, Zheng S. miR‑539 suppresses the proliferation, migration, invasion and epithelial mesenchymal transition of pancreatic cancer cells through targeting SP1. Int J Mol Med 2020;45:1771-82. [PMID: 32236568 DOI: 10.3892/ijmm.2020.4561] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Wu Chuang A, Kepp O, Kroemer G, Bezu L. Direct Cytotoxic and Indirect, Immune-Mediated Effects of Local Anesthetics Against Cancer. Front Oncol 2021;11:821785. [PMID: 35096626 DOI: 10.3389/fonc.2021.821785] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]